Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis

Journal of Diabetes

Volumn 8, Issue 1, 2016, Pages 56-62

  Zhang, Chun ^a,b   Ding, Zhi ^a   Lv, Guoqiang ^b   Li, Jianping ^b   Zhou, Ping ^b   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Diabetes; Irisin; Meta analysis

Indexed keywords

IRISIN; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PUBLICATION; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; META ANALYSIS; MOUSE; PROGNOSIS;

ANIMALS; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FIBRONECTINS; HUMANS; MICE; PROGNOSIS;

EID: 84954025520     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12256     Document Type: Article

References (17)

1. Eckardt K, Gorgens SW, Raschke S, Eckel J. Myokines in insulin resistance and type 2 diabetes. Diabetologia. 2014; 57: 1087-1099.
2. Hartwig S, Raschke S, Knebel B etal. Secretome profiling of primary human skeletal muscle cells. Biochim Biophys Acta. 2014; 1844: 1011-1017.
3. Raschke S, Eckardt K, Bjorklund Holven K, Jensen J, Eckel J. Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS ONE. 2013; 8: e62008.
4. Boström P, Wu J, Jedrychowski MP etal. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481: 463-468.
5. Liu JJ, Wong MD, Toy WC etal. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013; 27: 365-369.
6. Choi YK, Kim MK, Bae KH etal. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013; 100: 96-101.
7. Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis. 2014; 235: 328-333.
8. Zhang M, Chen P, Chen S etal. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: A preliminary study. Eur Rev Med Pharmacol Sci. 2014; 18: 1567-1572.
9. Alis R, Sanchis-Gomar F, Pareja-Galeano H etal. Association between irisin and homocysteine in euglycemic and diabetic subjects. Clin Biochem. 2014; 47: 333-335.
10. Sanchis-Gomar F, Alis R, Pareja-Galeano H etal. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine. 2014; 46: 674-677.
11. Sanchis-Gomar F, Alis R, Pareja-Galeano H, Romagnoli M, Perez-Quilis C. Inconsistency in circulating irisin levels: What is really happening? Horm Metab Res. 2014; 46: 591-596.
12. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012.
13. Moreno-Navarrete JM, Ortega F, Serrano M etal. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98: E769-778.
14. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991; 14: 1132-1143.
15. Frayn KN. Visceral fat and insulin resistance: Causative or correlative? Br J Nutr. 2000; 83 (Suppl. 1): S71-77.
16. Liu JJ, Liu S, Wong MD etal. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications. 2014; 28: 208-213.
17. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity: Correlation with body mass index. Peptides. 2013; 39: 125-130.